These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1397551)

  • 1. Sulphated polysaccharides exert anti-HIV activity at differing sites.
    Harrop HA; Rider CC; Coombe DR
    Biochem Soc Trans; 1992 May; 20(2):163S. PubMed ID: 1397551
    [No Abstract]   [Full Text] [Related]  

  • 2. Heparin specifically inhibits binding of V3 loop antibodies to HIV-1 gp120, an effect potentiated by CD4 binding.
    Harrop HA; Coombe DR; Rider CC
    AIDS; 1994 Feb; 8(2):183-92. PubMed ID: 8043225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4-derived peptide and sulfated polysaccharides have similar mechanisms of anti-HIV activity based on electrostatic interactions with positively charged gp120 fragments.
    Meshcheryakova D; Andreev S; Tarasova S; Sidorova M; Vafina M; Kornilaeva G; Karamov E; Khaitov R
    Mol Immunol; 1993 Aug; 30(11):993-1001. PubMed ID: 8102473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dextran sulfate and heparin interact with CD4 molecules to inhibit the binding of coat protein (gp120) of HIV.
    Lederman S; Gulick R; Chess L
    J Immunol; 1989 Aug; 143(4):1149-54. PubMed ID: 2545782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of entry of HIV into cells by poly(A).poly(U).
    Krust B; Callebaut C; Hovanessian AG
    AIDS Res Hum Retroviruses; 1993 Nov; 9(11):1087-90. PubMed ID: 8312051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of binding of rgp120 by anti-HIV active tannins.
    Weaver JL; Pine PS; Dutschman G; Cheng YC; Lee KH; Aszalos A
    Biochem Pharmacol; 1992 Jun; 43(11):2479-80. PubMed ID: 1610410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chloropeptins I and II, novel inhibitors against gp120-CD4 binding from Streptomyces sp.
    Matsuzaki K; Ikeda H; Ogino T; Matsumoto A; Woodruff HB; Tanaka H; Omura S
    J Antibiot (Tokyo); 1994 Oct; 47(10):1173-4. PubMed ID: 7961171
    [No Abstract]   [Full Text] [Related]  

  • 8. Heparin and its derivatives bind to HIV-1 recombinant envelope glycoproteins, rather than to recombinant HIV-1 receptor, CD4.
    Harrop HA; Rider CC
    Glycobiology; 1998 Feb; 8(2):131-7. PubMed ID: 9451022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ability of suramin to block CD4-gp120 binding is reversed in the presence of albumin.
    Yao XJ; Wainberg MA; Richard M; Pollak M
    Antimicrob Agents Chemother; 1991 Dec; 35(12):2636-8. PubMed ID: 1810199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfated polyanions prevent HIV infection of lymphocytes by disruption of the CD4-gp120 interaction, but do not inhibit monocyte infection.
    Lynch G; Low L; Li S; Sloane A; Adams S; Parish C; Kemp B; Cunningham AL
    J Leukoc Biol; 1994 Sep; 56(3):266-72. PubMed ID: 7521897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of anti-V3 domain antibody binding to human immunodeficiency virus type-1-infected cells by sulfated polysaccharides.
    Okada T; Patterson BK; Gurney ME
    Biochem Biophys Res Commun; 1995 Apr; 209(3):850-8. PubMed ID: 7537501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isochromophilones I and II, novel inhibitors against gp120-CD4 binding from Penicillium sp.
    Omura S; Tanaka H; Matsuzaki K; Ikeda H; Masuma R
    J Antibiot (Tokyo); 1993 Dec; 46(12):1908-11. PubMed ID: 8294253
    [No Abstract]   [Full Text] [Related]  

  • 13. Heparin mediates binding of S-protein/vitronectin to the envelope glycoprotein of the human immunodeficiency virus and CD4.
    Su HR; Boackle RJ
    Int Arch Allergy Immunol; 1994 Nov; 105(3):238-44. PubMed ID: 7522689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dextran sulfate and other polyanionic anti-HIV compounds specifically interact with the viral gp120 glycoprotein expressed by T-cells persistently infected with HIV-1.
    Schols D; Pauwels R; Desmyter J; De Clercq E
    Virology; 1990 Apr; 175(2):556-61. PubMed ID: 1691563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptidomimetic antagonists designed to inhibit the binding of CD4 to HIV GP120.
    Ramurthy S; Lee MS; Nakanishi H; Shen R; Kahn M
    Bioorg Med Chem; 1994 Sep; 2(9):1007-13. PubMed ID: 7712121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single basic amino acid substitutions at position 302 or 320 in the V3 domain of HIV type 1 are not sufficient to alter the antiviral activity of dextran sulfate and heparin.
    Okada T; Gurney ME
    AIDS Res Hum Retroviruses; 1995 May; 11(5):571-5. PubMed ID: 7576913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral effects of CD4 derivatives.
    Capon DJ; Ward RH
    Curr Opin Immunol; 1989-1990 Feb; 2(3):433-8. PubMed ID: 2576772
    [No Abstract]   [Full Text] [Related]  

  • 18. Molecular interaction between HIV-1 major envelope glycoprotein and dextran sulfate.
    Mbemba E; Chams V; Gluckman JC; Klatzmann D; Gattegno L
    Biochim Biophys Acta; 1992 Jan; 1138(1):62-7. PubMed ID: 1371075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human milk glycosaminoglycans inhibit HIV glycoprotein gp120 binding to its host cell CD4 receptor.
    Newburg DS; Linhardt RJ; Ampofo SA; Yolken RH
    J Nutr; 1995 Mar; 125(3):419-24. PubMed ID: 7876916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and inhibitory activities of isochromophilone analogues against gp120-CD4 binding.
    Sun XL; Takayanagi H; Matsuzaki K; Tanaka H; Furuhata K; Omura S
    J Antibiot (Tokyo); 1996 Jul; 49(7):689-92. PubMed ID: 8784432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.